This website does readability filtering of other pages. All styles, scripts, forms and ads are stripped. If you want your website excluded or have other feedback, use this form.

Apimostinel - Allergan - AdisInsight

Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Welcome to AdisInsight

Please enter your official email address Email Address Please enter your official email address Your email address will be used to create a unique number used exclusively to identify you on AdisInsight. Your email address will not be stored or maintained within AdisInsight. Your unique identifier number will be stored in your browser data on your device. This will allow us to know it’s you when you access AdisInsight from your computer, tablet, or phone. To do this you will need to enter your email address the first time to visit AdisInsight from a new device. After that we will recognize you and you will not have to enter your email again unless you have deleted your browser data. We will use your unique identifier number to provide anonymous information to your subscribing organization to allow them to accurately assess the value AdisInsight delivers. For additional information on how we protect your personal information, please refer to our privacy policy .

Apimostinel - Allergan

Next Previous

Search Advanced Search Structure Search Menu Drug Profile

Apimostinel - Allergan

Alternative Names: AGN 241660; NRX-1074

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Naurex
  • Developer Allergan; Naurex
  • Class Antidepressants; Small molecules
  • Mechanism of Action NMDA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Major depressive disorder

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 12 May 2017 Chemical structure information added
  • 26 Apr 2017 NRX-1074 is now called Apimostinel
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Login with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at [email protected] so we can help.

Table of Contents

210,000+ scientifically curated records

About Our Content

Other Sites

Help & Contacts

Downloads

Legal

Legal Adis International Ltd. Part of Springer Science+Business Media
© Springer Nature Switzerland AG Not logged in Unaffiliated 199.195.251.176